AC Health, the Ayala Group’s healthcare arm, aims to become a $2-billion enterprise by 2035 as it scales its integrated healthcare ecosystem and strengthens its presence nationwide.

President and CEO Paolo Borromeo announced the company’s long-term goals and strategic expansion plans on Friday. 

“We’re building a healthcare group designed for the long haul. We are backed by an ecosystem that is rooted in our commitment to providing quality, accessible healthcare for every Filipino,” Borromeo said. 

AC Health plans to deepen its presence in key cities by expanding its hospital and clinic network organically and inorganically. 

It will also broaden its retail pharma footprint nationwide through a multi-brand retail approach. 

Over the next three years, the company aims to grow its ecosystem to 1,150 retail pharmacies, 300 clinics and 10 hospitals.

“Our goal is to build a healthcare company that is not only financially resilient but also deeply transformative for Filipinos,” Borromeo said. “In 10 years, we’re going to be a $2-billion healthcare enterprise that serves one in every five Filipinos.”

Sales jump 10%

Since its first investment in Generika Drugstore in 2015, AC Health has grown into an integrated healthcare network that includes 236 corporate and multispecialty clinics and six hospitals under the Healthway Medical Network, 880 pharmacies under Generika Drugstore and St. Joseph Drug, and 1,178 certificates of product registration under I.E. Medica and MedEthix.

Last year, the company reported a 10 percent increase in revenues to P9.4 billion. 

Healthway Medical Network, its provider group, recorded 22 percent revenue growth, outperforming the hospital industry average of 8 percent. 

Its pharmaceutical group also surpassed the broader pharma market, which saw a 5 percent decline.